Casdin Partners Master Fund, L's Net Worth

Casdin Partners Master Fund, L's net worth is estimated to be at least $115,999,938.17 as of 05/04/2024. CoreStreet's estimation of Casdin Partners Master Fund, L's net worth is based on their sale of stock and current holding of stock.

Casdin Partners Master Fund, L is Director at Standard BioTools Inc.. They have executed at least 14 trades of stock as per SEC Form 4 filings. Their most recent trade was for 250,000 units of LAB stock on 03/04/2024. Their biggest sale was on 07/01/2022 when they sold 3,235,548 units of MaxCyte Inc stock for $13,912,856.40. They typically trade 2 times per year.

Total value of insider buys:
  • $97,561,997.87
Total value of insider sells:
  • $18,437,940.30
Most recent insider trade:
  • March 4, 2024

Casdin Partners Master Fund, L's Insider Trading History

Standard BioTools Inc.TitleAmountPriceTypeTotal Value
March 4, 2024
Director250,000$2.57Buy$642,500.00
BioLife Solutions IncTitleAmountPriceTypeTotal Value
Oct. 19, 2023
Major Shareholder927,165$11.19Buy$10,374,976.35
Aug. 9, 2023
Major Shareholder58,465$13.20Buy$771,738.00
May 22, 2023
Major Shareholder24,973$21.86Buy$545,909.78
May 18, 2023
Major Shareholder30,000$21.76Buy$652,800.00
May 16, 2023
Major Shareholder15,000$20.19Buy$302,850.00
Nov. 24, 2020
Major Shareholder1,600,000$22.50Buy$36,000,000.00
July 1, 2020
Major Shareholder685,000$14.50Buy$9,932,500.00
May 22, 2020
Major Shareholder476,191$16.14Buy$7,685,722.74
May 14, 2020
Major Shareholder1,904,762$10.50Buy$20,000,001.00
Nov. 19, 2019
Major Shareholder20,000$15.15Buy$303,000.00
MaxCyte IncTitleAmountPriceTypeTotal Value
Oct. 3, 2022
Major Shareholder735,786$6.15Sell$4,525,083.90
July 1, 2022
Major Shareholder3,235,548$4.30Sell$13,912,856.40
Decibel Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 17, 2021
Major Shareholder575,000$18.00Buy$10,350,000.00